Autism Spectrum Disorder Treatment Market Research Report – Segmentation By Type (Autistic Disorder, Asperger’s Syndrome, Pervasive Developmental Disorder - Not Otherwise Specified (PDD-NOS), Childhood Disintegrative Disorder (CDD), Other Types); Gender (Male, Female); Treatment (Behavioral Approaches, Early Intervention Programs, Medications, Dietary Approaches, and Complementary and Alternative Medicine); Drug Class (Antipsychotic Drugs, SSRIs/Antidepressants, Stimulants, Other Drug Classes); Drug Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies, Direct Selling, Mail Order Pharmacies); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-228
Format:
Region: Global
Chapter 1. AUTISM SPECTRUM DISORDER TREATMENT MARKET– Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. AUTISM SPECTRUM DISORDER TREATMENT MARKET– Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. AUTISM SPECTRUM DISORDER TREATMENT MARKET– Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. AUTISM SPECTRUM DISORDER TREATMENT MARKET- Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. AUTISM SPECTRUM DISORDER TREATMENT MARKET- Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. AUTISM SPECTRUM DISORDER TREATMENT MARKET– By Gender
6.1. Male
6.2. Female
Chapter 7. AUTISM SPECTRUM DISORDER TREATMENT MARKET– By Treatment
7.1. Behavioral Approaches
7.2. Applied Behavior Analysis (ABA)
7.3. Developmental, Individual Differences, Relationship-Based Approach (DIR)
7.4. Treatment and Education of Autistic and Related Communication-handicapped Children (TEACCH)
7.5. The Picture Exchange Communication System (PECS)
7.6. Early Intervention Programs
7.7. Medications
7.8. Antipsychotic Drugs
7.9. Selective Serotonin Reuptake Inhibitors (SSRIs)
7.10. Stimulants
7.11. Sleep Medications
7.12. Dietary Approaches
7.13. Complementary and Alternative Medicine
Chapter 8. AUTISM SPECTRUM DISORDER TREATMENT MARKET– By Type
8.1 Autistic Disorder
8.2. Asperger’s Syndrome
8.3. Pervasive Developmental Disorder - Not Otherwise Specified (PDD-NOS)
8.4. Childhood Disintegrative Disorder (CDD)
8.5. Other Types
Chapter 9. AUTISM SPECTRUM DISORDER TREATMENT MARKET– By Drug Class
9.1 Antipsychotic Drugs
9.2. SSRIs/Antidepressants
9.3. Stimulants
9.4. Other Drug Classes
Chapter 10. AUTISM SPECTRUM DISORDER TREATMENT MARKET– By Drug Distribution Channel
10.1 Hospital Pharmacies
10.2. Drug Stores & Retail Pharmacies
10.3. Online Pharmacies
10.4. Direct Selling
10.5. Mail Order Pharmacies
Chapter 11. AUTISM SPECTRUM DISORDER TREATMENT MARKET– By Region
11.1. North America
11.2. Europe
11.3.The Asia Pacific
11.4.Latin America
11.5. Middle-East and Africa
Chapter 12. AUTISM SPECTRUM DISORDER TREATMENT MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)
12.1. Curemark LLC
12.2. Bristol-Myers Squibb Company
12.3. Merck & Co., Inc.
12.4. Novartis AG
12.5. Eli Lilly and Company
12.6. Pfizer Inc.
12.7. Johnson & Johnson Services Inc.
12.8. Otsuka Pharmaceutical Co., Ltd.
12.9. Yamo Pharmaceuticals
12.10. F.Hoffmann-La Roche Ltd.
12.11. Axial Therapeutics Inc.
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
Global Autism Spectrum Disorder Treatment Market is estimated to be worth USD 2.04 Billion in 2022 and is projected to reach a value of USD 3.61 Billion by 2030, growing at a CAGR of 7.4% during the forecast period 2023-2030.
The Global Autism Spectrum Disorder Treatment Market is driven by Increasing Awareness and Early Diagnosis.
The Segments under the Global Autism Spectrum Disorder Treatment Market by Gender are Male and Female
China, Japan, South Korea, Singapore, and India are the most dominating countries in the Asia Pacific region for the Global Autism Spectrum Disorder Treatment Market.
Curemark LLC, Bristol-Myers Squibb Company, and Merck & Co., Inc. are the three major leading players in the Global Autism Spectrum Disorder Treatment Market
